Quoin Pharmaceuticals Ltd. Expense Breakdown
No Expense Breakdown for QNRX on this site yet.
- 2026-06-30: Single reportable segment $3.63M.
- 2025-06-30: Single reportable segment $2.05M.
Source checked: the stored Expense Breakdown page for QNRX.
Expenses by product
Research and development: each quarter (3 month)
| Quarter end | Single reportable segment |
|---|
| 2026-06-30 | $3.63M |
|---|
| 2025-06-30 | $2.05M |
|---|
Research And Development Expense External Clinical Development: each quarter (3 month)
| Quarter end | Single reportable segment |
|---|
| 2026-06-30 | $2.48M |
|---|
| 2025-06-30 | $1.64M |
|---|
Research And Development Expense Personnel Related And Stock Based Compensation: each quarter (3 month)
| Quarter end | Single reportable segment |
|---|
| 2026-06-30 | $1.03M |
|---|
| 2025-06-30 | $258.07K |
|---|